Y-Intercept (HK)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-70,095
Closed -$345K 2030
2024
Q1
$345K Buy
+70,095
New +$345K 0.03% 893
2023
Q2
Sell
-10,009
Closed -$322K 1811
2023
Q1
$322K Buy
+10,009
New +$322K 0.04% 734